From Self-sufficiency
Revision as of 07:48, 4 August 2010 by Eyad Hylooz (Talk) (Adding reference for treatment of diarrhea-predominant irritable bowel syndrome in males + one minor edit (male => males).)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Systematic (IUPAC) name
Clinical data
Routes of
Pharmacokinetic data
Biological half-life 5.8 hours
CAS Number 132907-72-3
ATC code none
PubChem CID 108000
Chemical data
Formula C17H17N3O
Molar mass 279.33 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Ramosetron (INN) is a serotonin 5-HT3 receptor antagonist for the treatment of nausea and vomiting.[1] Ramosetron is also indicated for a treatment of “diarrhea-predominant irritable bowel syndrome in males”.[2] In India it is marketed under the brand name of "IBset".

It is only licensed for use in Japan and selected Southeast Asian countries. It is commonly sold under the tradename Nasea and in India as Nozia (300 mcg/ml Inj. & 100 mcg Tab.) [3]


Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

ja:ラモセトロン pt:Ramosetrona
  1. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  2. http://www.astellas.com/en/corporate/news/detail/astellas-launches-irribow-for.html
  3. Abriged prescribing information - Nasea (MIMS Philippines). Retrieved on June 13, 2008.